Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia

Canadian Respiratory Journal

Volumn 18, Issue 3, 2011, Pages 131-136

  Delisle, Marie Soleil ^a   Williamson, David R ^b   Albert, Martin ^b   Perreault, Marc M ^c   Jiang, Xuran ^d   Day, Andrew G ^d   Heyland, Daren K ^d,e  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d KINGSTON GENERAL HOSPITAL   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Candida infection; Critical care; Intensive care; Nosocomial infection; Pneumonia

Indexed keywords

ADULT; ARTICLE; CANADA; CANDIDA; COMORBIDITY; CRITICALLY ILL PATIENT; FEMALE; FUNGUS CULTURE; HAZARD RATIO; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCORING SYSTEM; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84860588363     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/827692     Document Type: Article

References (36)

1. Cook DJ, Kollef MH. Risk factors for ICU-acquired pneumonia. JAMA 1998;279:1605-6.
2. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review. Crit Care Med 2005;33:2184-93.
3. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-44.
4. Rello J, Quintana E, Ausina V, et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991;100:439-44.
5. Celis R, Torres A, Gatell JM, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988;93:318-24. (Pubitemid 18053068)
6. Craven DE, Kunches LM, Lichtenberg DA, et al. Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988;148:1161-8.
7. Jimenez P, Torres A, Rodriguez-Roisin R, et al. Incidence and etiology of pneumonia acquired during mechanical ventilation. Crit Care Med 1989;17:882-5. (Pubitemid 19233317)
8. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996;275:866-9. (Pubitemid 26087224)
9. Kerver AJ, Rommes JH, Mevissen-Verhage EA, et al. Colonization and infection in surgical intensive care patients - a prospective study. Intensive Care Med 1987;13:347-51. (Pubitemid 17112390)
10. Heyland DK, Cook D, Dodek P, Muscedere J, Day A. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006;355:2619-30. (Pubitemid 44969121)
11. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006;129:1210-8.
12. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997;111:676-85. (Pubitemid 27132946)
13. Michel F, Franceschini B, Berger P, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: A role for routine endotracheal aspirate cultures. Chest 2005;127:589-97. (Pubitemid 40229322)
14. Muscedere JG, Martin CM, Heyland DK. The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care 2008;23:5-10. (Pubitemid 351400351)
15. Leon C, Ruiz-Santana S, Saavedra P, et al. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study. Crit Care Med 2009;37:1624-33.
16. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-8. (Pubitemid 24376373)
17. Charles PE, Dalle F, Aube H, et al. Candida spp. colonization significance in critically ill medical patients: A prospective study. Intensive Care Med 2005;31:393-400.
18. Eggimann P, Pittet D. Candidiasis among non-neutropenic patients: From colonization to infection. Ann Fr Anesth Reanim 2001;20:382-8. (Pubitemid 32428434)
19. el-Ebiary M, Torres A, Fabregas N, et al. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 1997;156:583-90.
20. Wood GC, Mueller EW, Croce MA, Boucher BA, Fabian TC. Candida sp. isolated from bronchoalveolar lavage: Clinical significance in critically ill trauma patients. Intensive Care Med 2006;32:599-603.
21. Meersseman W, Lagrou K, Spriet I, et al. Significance of the isolation of Candida species from airway samples in critically ill patients: A prospective, autopsy study. Intensive Care Med 2009;35:1526-31.
22. Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J. The role of Candida sp isolated from bronchoscopic samples in non-neutropenic patients. Chest 1998;114:146-9. (Pubitemid 28337375)
23. Azoulay E, Timsit JF, Tafflet M, et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 2006;129:110-7. (Pubitemid 43265250)
24. Delisle MS, Williamson DR, Perreault MM, Albert M, Jiang X, Heyland DK. The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care 2008;23:11-7. (Pubitemid 351400358)
25. Heyland DK, Dodek P, Muscedere J, Day A, Cook D. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 2008;36:737-44.
26. Harrell FE. Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis. New York: Springer, 2001.
27. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley, 1989.
28. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-41.
29. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81.
30. Olaechea PM, Palomar M, Leon-Gil C, et al. Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004;23:323-30. (Pubitemid 38669943)
31. Young SH, Ostroff GR, Zeidler-Erdely PC, Roberts JR, Antonini JM, Castranova V. A comparison of the pulmonary inflammatory potential of different components of yeast cell wall. J Toxicol Environ Health A 2007;70:1116-24. (Pubitemid 46897797)
32. Roux D, Gaudry S, Dreyfuss D, et al. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit Care Med 2009;37:1062-7.
33. Williamson D, Albert M, Delisle MS, et al. Effect of Candida Spp. in respiratory tract secretions on systemic inflammation. Crit Care Med 2008;36:A115.
34. Nseir S, Jozefowicz E, Cavestri B, et al. Impact of antifungal treatment on Candida-Pseudomonas interaction: A preliminary retrospective case-control study. Intensive Care Med 2007;33:137-42. (Pubitemid 46115481)
35. Leon C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system ("Candida score") for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med 2006;34:730-7.
36. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17. (Pubitemid 39050477)